Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Abraham

Showing results (581-590 of 1,061) with videos related to

Pageof 107
Sort By:
Circulation. Arrhythmia and Electrophysiology|October 16, 2013
Implantable defibrillators improve survival in patients with mildly symptomatic heart failure receiving cardiac resynchronization therapy: analysis of the long-term follow-up of remodeling in systolic left ventricular dysfunction (REVERSE)Michael R Gold, Jean-Claude Daubert, William T Abraham, et al.
The Journal of Biological Chemistry|March 8, 2008
A protective role for the human SMG-1 kinase against tumor necrosis factor-alpha-induced apoptosisVasco Oliveira, William J Romanow, Christoph Geisen, et al.
Journal of Investigative Surgery : the Official Journal of the Academy of Surgical Research|May 26, 2010
The effect of butyrate on the healing of colonic anastomoses in ratsA J Mathew, V C Wann, D T Abraham, et al.
Journal of Immunology (Baltimore, Md. : 1950)|March 1, 1990
Regulatory effects of transforming growth factor-beta on IL-2- and IL-4-dependent T cell-cycle progressionJ J Ruegemer, S N Ho, J A Augustine, et al.
Journal of the American College of Cardiology|December 17, 2016
Natriuretic Peptides, 6-Min Walk Test, and Quality-of-Life Questionnaires as Clinically Meaningful Endpoints in HF TrialsJoão Pedro Ferreira, Kevin Duarte, Todd L Graves, et al.
ESC Heart Failure|September 30, 2024
Device-therapy in chronic heart failure: Cardiac contractility modulation versus cardiac resynchronization therapyGoekhan Yuecel, Leo Gaasch, Abbass Kodeih, et al.
Genes & Development|June 11, 1999
Regulation of 4E-BP1 phosphorylation: a novel two-step mechanismA C Gingras, S P Gygi, B Raught, et al.
Critical Pathways in Cardiology|March 15, 2008
Role of beta-blocker therapy in the postmyocardial infarction patient with and without left ventricular dysfunction consensus guidelineGregg C Fonarow, William T Abraham, Mihai Gheorghiade, et al.
European Heart Journal|January 31, 2012
Sites of left and right ventricular lead implantation and response to cardiac resynchronization therapy observations from the REVERSE trialChristophe Thébault, Erwan Donal, Catherine Meunier, et al.
Congestive Heart Failure (Greenwich, Conn.)|October 8, 2004
Prevalence of sleep disordered breathing in a heart failure programRobin J Trupp, Peggy Hardesty, Julia Osborne, et al.
Pageof 107

Showing results (581-590 of 1,061) with videos related to

Sort By:
Pageof 107
Circulation. Arrhythmia and Electrophysiology|October 16, 2013
Implantable defibrillators improve survival in patients with mildly symptomatic heart failure receiving cardiac resynchronization therapy: analysis of the long-term follow-up of remodeling in systolic left ventricular dysfunction (REVERSE)Michael R Gold, Jean-Claude Daubert, William T Abraham, et al.
The Journal of Biological Chemistry|March 8, 2008
A protective role for the human SMG-1 kinase against tumor necrosis factor-alpha-induced apoptosisVasco Oliveira, William J Romanow, Christoph Geisen, et al.
Journal of Investigative Surgery : the Official Journal of the Academy of Surgical Research|May 26, 2010
The effect of butyrate on the healing of colonic anastomoses in ratsA J Mathew, V C Wann, D T Abraham, et al.
Journal of Immunology (Baltimore, Md. : 1950)|March 1, 1990
Regulatory effects of transforming growth factor-beta on IL-2- and IL-4-dependent T cell-cycle progressionJ J Ruegemer, S N Ho, J A Augustine, et al.
Journal of the American College of Cardiology|December 17, 2016
Natriuretic Peptides, 6-Min Walk Test, and Quality-of-Life Questionnaires as Clinically Meaningful Endpoints in HF TrialsJoão Pedro Ferreira, Kevin Duarte, Todd L Graves, et al.
ESC Heart Failure|September 30, 2024
Device-therapy in chronic heart failure: Cardiac contractility modulation versus cardiac resynchronization therapyGoekhan Yuecel, Leo Gaasch, Abbass Kodeih, et al.
Genes & Development|June 11, 1999
Regulation of 4E-BP1 phosphorylation: a novel two-step mechanismA C Gingras, S P Gygi, B Raught, et al.
Critical Pathways in Cardiology|March 15, 2008
Role of beta-blocker therapy in the postmyocardial infarction patient with and without left ventricular dysfunction consensus guidelineGregg C Fonarow, William T Abraham, Mihai Gheorghiade, et al.
European Heart Journal|January 31, 2012
Sites of left and right ventricular lead implantation and response to cardiac resynchronization therapy observations from the REVERSE trialChristophe Thébault, Erwan Donal, Catherine Meunier, et al.
Congestive Heart Failure (Greenwich, Conn.)|October 8, 2004
Prevalence of sleep disordered breathing in a heart failure programRobin J Trupp, Peggy Hardesty, Julia Osborne, et al.
Pageof 107